Tcf7l1 Acts as a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and Is Regulated by IGF/MEK/ERK Signaling Independent of β-Catenin
Tcf7l1 Acts as a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and Is Regulated by IGF/MEK/ERK Signaling Independent of β-Catenin
复制标题
Tcf7l1 作为肝癌干细胞自我更新的抑制剂,并受 IGF/MEK/ERK 信号传导的调节,独立于 β-Catenin
DOI:
10.1002/stem.3063
复制
发表时间:
2019-08-26
期刊:
影响因子:
5.2
通讯作者:
Qian, Cheng
中科院分区:
文献类型:
--
作者:
Shan, Juanjuan;Shen, Junjie;Qian, Cheng
Tcf7l1, which is a key effector molecule of the Wnt/beta-catenin signaling pathway, is highly expressed in various cancers, and it promotes tumor growth. In this study, we demonstrated that unlike its tumor-promoting effects in several other types of cancers, Tcf7l1 expression is downregulated in hepatocarcinoma compared with their adjacent nontumor counterparts. Underexpression of Tcf7l1 is correlated with poorer survival. In liver cancer stem cell (CSC) populations, Tcf7l1 expression is downregulated. Ectopic expression of Tcf7l1 attenuates the self-renewal abilities of liver CSCs. Mechanistically, Tcf7l1 regulates the self-renewal abilities of liver CSCs through transcriptional repression of the Nanog gene, and the effect is independent of beta-catenin. Moreover, we found that Tcf7l1 expression is controlled by extracellular insulin-likegrowth factor (IGF) signaling, and we demonstrated for the first time that IGF signaling stimulates Tcf7l1 phosphorylation and degradation through the mitogen-activated protein kinase (MEK)/extracellularsignal-regulated kinase (ERK) pathway. Overall, our results provide some new insights into how extracellular signals modulate the self-renewal of liver CSCs and highlight the inhibitory roles of Tcf7l1 in cancer. Stem Cells 2019